SCID Angels for Life Research Grant

SCID Angels for Life Research Grant is sponsored by SCID Angels for Life. This grant aims to improve long-term outcomes and/or reduce treatment-related long-term complications, thereby improving quality of life post-treatment, and to find innovative approaches aimed at improving the diagnosis, the treatment, or maintaining the treatment continuity of …

SCID Angels awards research grants | Immune Deficiency Foundation Understanding primary immunodeficiency (PI) How your immune system works Could it be your immune system? Preventative antimicrobials Immunoglobulin replacement therapy Hematopoietic stem cell transplantation The more you understand about primary immunodeficiency (PI), the better you can manage it. Learn about PI diagnoses and treatment options.

Explaining your diagnosis Digestive and liver health IDF Friends online community Caring for children and teens Appeal or file a complaint Living with primary immunodeficiency (PI) can be challenging, but you’re not alone—many people with PI lead full and active lives. With the right support and resources, you can, too. Learn more about living with PI Be a hero for those with PI.

Change lives by promoting primary immunodeficiency (PI) awareness and taking action in your community through advocacy, donating, volunteering, or fundraising. Advancing research and clinical care Getting prior authorization Participating in clinical research Advancing research and clinical care Whether you’re a clinician, researcher, or an individual with primary immunodeficiency (PI), these resources will help you advance the field.

Get details on surveys, grants, and clinical trials. Learn more about research SCID Angels awards research grants Long known for being a hub where parents of children, as well as adults, with severe combined immunodeficiency (SCID) can connect and share information, SCID, Angels for Life is now branching out to fund research into this life-threatening primary immunodeficiency.

Last week, SCID Angels awarded one-year grants to SCID experts for two projects. One lays the groundwork for gene editing as a treatment for IL7Rα SCID . The other analyzes a variant of RAG1 SCID in the Mennonite community to improve diagnosis and treatment for those families affected.

“We’re thrilled to see researchers develop both a new treatment approach to SCID and explore ways to assist a marginalized community in coping with the diagnosis,” said Smith. “This is our first shot at providing grants for research and we didn’t know what to expect. To receive such different applications that met each of our areas of interest blew us out of the water.

” The program was created thanks to a $25,000 grant from ADMA Biologics, a company that produces plasma products for people with rare diseases. The generosity of an anonymous donor made an additional research grant possible. “We are grateful to ADMA who knew this was our first attempt to provide a research grant,” said Smith.

Dr. Donald Kohn, a specialist in bone marrow transplantation and gene therapy at the University of California, Los Angeles, will oversee the grant to develop a gene-editing technology for the treatment of IL7Rα SCID. Kohn’s research explores the creation of the technology to make the changes in the IL7Rα gene, which lays the groundwork for testing the technology going forward.

This early-stage development of gene editing to treat IL7Rα SCID will be conducted by a junior faculty member at UCLA. “We’re excited to get some of these new young researchers involved in SCID,” said Smith. Dr. Jolan Walter, an allergy and immunology specialist at the University of South Florida, will study Mennonite communities that are affected by RAG1 p.

C176F SCID, a variant of SCID that ranges in severity and is known as atypical, or leaky, SCID. The Mennonite communities reside in Pennsylvania, Virginia, North Carolina, and Ohio, and are marginalized regarding their health and healthcare needs, due to cultural and economic differences.

The study aims to increase awareness of the RAG1 variant among Mennonite community members and empower them to seek genetic screening and follow-up care. The research is also expected to provide data leading to preventive and therapeutic strategies designed to reduce disease severity for those who inherit the RAG1 variant, and other variants of atypical SCID with variable presentations.

SCID Angels Director Barb Ballard said the organization is fortunate to be able to award the grants, and she hopes that funding is secured annually for such projects. “As a rare disease, SCID is often overlooked for research grant funding, yet historically so many important therapies, such as bone marrow transplants , have come out of research looking to treat SCID patients.

The results have benefited not only SCID patients but patients in many other disease groups as well,” said Ballard. “Meanwhile, there are so many forms of SCID that still need the earliest stages of research to make progress. This means there will be many more areas that will need small kickstarter grants such as this.

” Severe combined immune deficiency (SCID) Advancements in plasma collection and therapeutic applications 2026 research grant application Wiskott-Aldrich syndrome study shows carriers have symptoms Receive news and helpful resources to your cell phone or inbox. You can change or cancel your subscription at any time.

Immune Deficiency Foundation 7550 Teague Road, Suite 220 The Immune Deficiency Foundation improves the diagnosis, treatment, and quality of life for every person affected by primary immunodeficiency. ​ We foster a community that is connected, engaged, and empowered through advocacy, education, and research.